AMOXIRUM FORTE INJ
₹64
AMOXIRUM FORTE INJ 300MG is a highly effective injectable antibiotic designed for the treatment of various bacterial infections in dogs and cats. Manufactured by VIRBAC, this 5ML vial product contains a combination of Amoxycillin and Sulbactam Sodium, ensuring broad-spectrum efficacy. Animeal is proud to offer this product, highlighting our commitment to delivering quality veterinary solutions.
Estimated Delivery Date: January 28, 2025
Key Ingredients: Amoxycillin Sodium: Equates to 200 mg of Amoxycillin, a penicillin antibiotic that destroys susceptible bacteria by preventing the formation of their cell wall​​​​.
Sulbactam Sodium: Equates to 100 mg, Sulbactam enhances the efficacy of Amoxycillin by preventing the destruction of the antibiotic by beta-lactamase enzymes produced by certain bacteria​​​​.
Features / Benefits
Key Features: Broad-Spectrum Action: Effective against a variety of infections including respiratory, skin, urinary, and soft tissue infections​​​​.
Enhanced Stability: The addition of Sulbactam prevents the degradation of Amoxycillin, ensuring its effectiveness against beta-lactamase producing bacteria​​.
Uses and Benefits: AMOXIRUM FORTE INJ 300MG is invaluable in treating infections such as urinary tract infections, respiratory conditions, and skin infections in pets​​​​.
Direction of Use: For dogs, the recommended dosage is 10-20 mg/kg body weight every 8-12 hours, administered intravenously (IV) or intramuscularly (IM)​​. Consultation with a veterinarian is essential to determine the appropriate dosage and treatment duration.
Mechanism of Action: AMOXIRUM FORTE INJ 300MG works by preventing the bacteria from forming their cell walls, leading to their destruction​​.
Precautions: Typically well-tolerated with a low risk of toxicity. However, caution is advised in animals with penicillin allergies​​​​.
Side effects can include gastrointestinal issues like vomiting and diarrhea​​.
Dosage Form: Injection
General Inquiries
There are no inquiries yet.
Reviews
There are no reviews yet.